bezafibrate has been researched along with natriuretic peptide, brain in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, Y; Behar, S; Boyko, V; Fisman, EZ; Goldberg, I; Inoue, T; Matas, Z; Node, K; Schwammenthal, E; Tenenbaum, A | 1 |
Bandyopadhyay, A; Kar, D | 1 |
2 other study(ies) available for bezafibrate and natriuretic peptide, brain
Article | Year |
---|---|
Long-term effects of peroxisome proliferator-activated receptor ligand bezafibrate on N-terminal pro-B type natriuretic peptide in patients with advanced functional capacity impairment.
Topics: Aged; Bezafibrate; Coronary Artery Disease; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Hypolipidemic Agents; Insulin Resistance; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Peroxisome Proliferator-Activated Receptors; PPAR gamma; Randomized Controlled Trials as Topic; Severity of Illness Index | 2009 |
Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes.
Topics: Animals; Animals, Newborn; Antagomirs; Atrial Natriuretic Factor; Bezafibrate; Calcium; Cell Enlargement; Cells, Cultured; MicroRNAs; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oxidative Stress; Phenylephrine; PPAR alpha; Rats; Rats, Sprague-Dawley; Signal Transduction; Voltage-Dependent Anion Channels | 2018 |